Nebenwirkungen · Betaferon
Betaferon 250 microgram/ml, powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-085141 · Präparat HOS-083087
Summary of the safety profile At the beginning of treatment adverse reactions are common but in general they subside with further treatment. The most frequently observed adverse reactions are a flu-like symptom complex (fever, chills, arthralgia, malaise, sweating, headache, or myalgia), which is mainly due to the pharmacological effects of the medicinal product, and injection site reactions. Injection site reactions occurred frequently after administration of Betaferon. Redness, swelling, discolouration, inflammation, pain, hypersensitivity, infection, necrosis and non-specific reactions were significantly associated with 250 microgram (8.0 million IU) Betaferon treatment. The most serious adverse reactions reported include thrombotic microangiopathy (TMA) and haemolytic anaemia (HA).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-11-24T11:42:00Z · SHA-256 73002d6eb728583b13eb94f0947d2c951ea9003845f9750afc924bebe2f83959 · Passage 43f4b3cbbd3c794d94e8fde1f6681cdc2b5859390e6797d5137b9cb6bba01bd9 · Zeichen 0–796 im Abschnitt